Bar-Or A - Search Results

1

Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.

Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR. Cree BA, et al. Arch Neurol. 2009 Feb;66(2):226-33. doi: 10.1001/archneurol.2008.541. Arch Neurol. 2009. PMID: 19204159 Free PMC article.

2

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

Stüve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK. Stüve O, et al. Arch Neurol. 2006 Oct;63(10):1383-7. doi: 10.1001/archneur.63.10.1383. Arch Neurol. 2006. PMID: 17030653 Clinical Trial.

3

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.

Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Banwell B, et al. Neurology. 2008 Jan 29;70(5):344-52. doi: 10.1212/01.wnl.0000284600.80782.d5. Epub 2007 Dec 19. Neurology. 2008. PMID: 18094334

4

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH; HERMES Trial Group. Hauser SL, et al. N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383. N Engl J Med. 2008. PMID: 18272891 Free article. Clinical Trial.

5

GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.

Goodman AD, Rossman H, Bar-Or A, Miller A, Miller DH, Schmierer K, Lublin F, Khan O, Bormann NM, Yang M, Panzara MA, Sandrock AW; GLANCE Investigators. Goodman AD, et al. Neurology. 2009 Mar 3;72(9):806-12. doi: 10.1212/01.wnl.0000343880.13764.69. Neurology. 2009. PMID: 19255407 Free PMC article. Clinical Trial.

6

Chronic cerebrospinal venous insufficiency and multiple sclerosis.

Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, Trapp B, Bar-Or A, Zak I, Siegel MJ, Lisak R. Khan O, et al. Ann Neurol. 2010 Mar;67(3):286-90. doi: 10.1002/ana.22001. Ann Neurol. 2010. PMID: 20373339 Free article.

7

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P. Burton JM, et al. Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Neurology. 2010. PMID: 20427749 Free PMC article. Clinical Trial.

8

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH. Bar-Or A, et al. Ann Neurol. 2010 Apr;67(4):452-61. doi: 10.1002/ana.21939. Ann Neurol. 2010. PMID: 20437580 Clinical Trial.

9

Therapies for multiple sclerosis: considerations in the pediatric patient.

Banwell B, Bar-Or A, Giovannoni G, Dale RC, Tardieu M. Banwell B, et al. Nat Rev Neurol. 2011 Feb;7(2):109-22. doi: 10.1038/nrneurol.2010.198. Epub 2011 Jan 11. Nat Rev Neurol. 2011. PMID: 21224883 Review.

10

HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.

Disanto G, Magalhaes S, Handel AE, Morrison KM, Sadovnick AD, Ebers GC, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network. Disanto G, et al. Neurology. 2011 Mar 1;76(9):781-6. doi: 10.1212/WNL.0b013e31820ee1cd. Epub 2011 Feb 2. Neurology. 2011. PMID: 21288988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page